dos Santos, Q.; Wareham, N.E.; Mocroft, A.; Rasmussen, A.; Gustafsson, F.; Perch, M.; Sørensen, S.S.; Manuel, O.; Müller, N.J.; Lundgren, J.;
et al. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Cancers 2022, 14, 3279.
https://doi.org/10.3390/cancers14133279
AMA Style
dos Santos Q, Wareham NE, Mocroft A, Rasmussen A, Gustafsson F, Perch M, Sørensen SS, Manuel O, Müller NJ, Lundgren J,
et al. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Cancers. 2022; 14(13):3279.
https://doi.org/10.3390/cancers14133279
Chicago/Turabian Style
dos Santos, Quenia, Neval Ete Wareham, Amanda Mocroft, Allan Rasmussen, Finn Gustafsson, Michael Perch, Søren Schwartz Sørensen, Oriol Manuel, Nicolas J. Müller, Jens Lundgren,
and et al. 2022. "Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients" Cancers 14, no. 13: 3279.
https://doi.org/10.3390/cancers14133279
APA Style
dos Santos, Q., Wareham, N. E., Mocroft, A., Rasmussen, A., Gustafsson, F., Perch, M., Sørensen, S. S., Manuel, O., Müller, N. J., Lundgren, J., & Reekie, J.
(2022). Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Cancers, 14(13), 3279.
https://doi.org/10.3390/cancers14133279